Blood Preparation Market Size, Share & Trends Analysis Report by Product (Derivatives, Whole Blood, and Components), By Antithrombotic and Anticoagulants Type (Fibrinolytic, Platelet Aggregation Inhibitors, and Anticoagulants), By Application (Thrombocytosis, Renal Impairment, Angina Complications, Pulmonary Embolism, and others) and By Geography (EU, NA, APAC, LATAM, and MEA) – Analysis, Size, Share, Trends, & Forecast from 2021-2027
"
REPORT HIGHLIGHT
The global blood preparation market was valued at USD 38.9 billion by 2019, growing with 6.2% CAGR during the forecast period, 2021-2027.
Blood comprises various components such as plasma, RBCs, platelets, and white blood cells that circulate in the body and offer oxygen, nutrition, and eliminates waste from the human body. In hospitals & clinics, the body fluid is collected and separated into beneficial components before transfusion. Individuals need a transfusion in many conditions such as operations, while liver disorders halt the human body from producing blood and lead to hemorrhage diseases. Previously whole blood was frequently collected and separated, but now because of mechanized collections, only components that are desirable for transfusion are collected. Nowadays, automate collections are becoming progressively popular, and only components required for the transfusion of blood are collected for the tests.
Market Dynamics
The increasing incidence of blood disorders demanding transfusion will act as a tremendous impacting factor for blood preparation market growth during the analysis period. Also, infectious disorders such as breakbone fever (dengue) lead to growth in the need for platelet transfusion and products.
Robust product pipeline of anticoagulant and anti-thrombotic drugs combined with increasing awareness regarding blood donation in emerging nations should impel blood preparation market growth. The growing number of occupational and road accidents and rising elderly population base, mainly suffering from chronic disorders such as hemochromatosis and liver cirrhosis, will undoubtedly impact the blood preparation market's growth. Also, the increasing applications of derivatives, including platelet-rich plasma in therapies, including anti-aging, are likely to boost blood preparation market growth over the prediction period. Nevertheless, the high risk of disease transmissions such as AIDS, HIV, syphilis, Hepatitis B, and C, resulting due to transfusion, will restrict business expansion to a certain extent over the forecast period.
Product Takeaway
The global business is classified into derivatives, whole blood, and components based on product. The whole blood segment accounted for the lion's share in the blood preparation market in terms of both volume and value in 2019 and is projected to grow at a notable CAGR during the analysis period. Snowballing demand for whole blood for transfusions and surgeries along with its advantages, such as low cost, easy availability, and maintenance is driving the blood preparation market growth.
Derivatives are projected to be the fastest-growing segment over the forecast period. The existence of various government initiatives for the expansion of plasma-derived proteins, such as coagulation factor products, immunoglobulins, dried human plasma, human fibrin foam, and human thrombin, is anticipated to drive segment growth.
Antithrombotic and Anticoagulants Type Takeaway
The worldwide industry is categorized into fibrinolytic, platelet aggregation inhibitors, and anticoagulants in terms of application. The anticoagulants segment is likely to dominate the blood preparation market growth shortly. Rising acceptance of anti-thrombotic drugs to decrease mortality due to thrombosis is driving the industry growth. According to the reports published by the National Institute of Health 2018 data, about 100,000 to 400,000 individuals in the United States die due to venous thrombosis every year. Rising investments towards the development of novel anticoagulant drugs are likely to boost the anti-coagulants market. Recently developed anticoagulant drugs include factor tissue factor inhibitor, direct thrombin inhibitor, Xa inhibitor, novel vitamin K antagonists, and factor IX inhibitor.
Major pharmaceutical companies are upgrading products by introducing innovative and more effective anticoagulant drugs in the market. The re-launch of few important drug products, such as Urokinase, is predicted to spur its growth in the forecast period. Anticoagulant drugs include vitamin K antagonists, direct factor Xa inhibitors, heparins, and direct thrombin inhibitors.
Application Takeaway
The global business is classified into thrombocytosis, renal impairment, angina complications, pulmonary embolism, and others based on application. The thrombocytosis segment accounted for a remarkable share in the blood preparation market in terms of both volume and value in 2019 and is expected to grow at a striking growth rate by 2027. Antithrombotic products are extensively employed in thrombocytosis, a condition of high platelets. Higher platelet count leads to clotting of body fluids in the body, which eventually causes deadly conditions.
Angina complications are projected to rise at the fastest CAGR during the forecast period due to growing research & development for anticoagulants' growth for cardiac problems. Angina pectoris is characterized by discomfort and extreme pain in the chest due to the heart's inadequate oxygen supply. Although the initial treatment for angina is nitroglycerine, the use of anticoagulants is momentous due to the incidence of complications in the nitroglycerine treatment.
Regional Takeaway
Regionally, the overall industry is divided into Europe, North America, Middle East & Africa, Asia Pacific, and Latin America. North America is a significant regional blood preparation market due to ultra-modern healthcare infrastructure and hi-technology usage for treatment purposes. In the United States, the whole process of transfusion from collection to separation to preparation to storage is regulated by the USFDA.
On the flip side, Asia Pacific accounted as the fastest-growing segment for the blood preparation market. Various governments, particularly in India and China, are spreading support for technological advancements in procedures. The constant growth of the healthcare sector in Japan and Australia is likely to boost the blood preparation market's growth in this region.
COVID-19 Impact
The emergence of the COVID-19 pandemic brought the world together to a standstill. The vast health crisis due to the virus also brought an unusual impact on numerous businesses across every vertical. However, the blood preparation market has seen a constant growth owing to the continuous requirement of different components during surgeries. Nevertheless, the closure of production sites and the impact on global trade have also affected the other side.
Key Vendor Takeaway
The leading players include GlaxoSmithKline, Boehringer Ingelheim, AstraZeneca, Pfizer, Bayer, Aralez Pharmaceuticals, Johnson and Johnson, Leo Pharma, Bristol-Myers, Ionis Pharmaceuticals, and Daiichi Sankyo, among others.
The principal players are actively adopting several strategies such as geographical expansion, acquisition, product development of new and efficient technologies, etc., to maintain their position in the market. In September 2019, B. Braun launched the First FDA-Approved Heparin Sodium Prefilled Syringe with an attached safety needle.
The market size and forecast for each segment and sub-segments has been considered as below:
- Historical Year – 2016 to 2018
- Base Year – 2019
- Estimated Year – 2020
- Projected Year – 2021 to 2027
TARGET AUDIENCE
- Traders, Distributors, and Suppliers
- Manufacturers
- Government and Regional Agencies
- Research Organizations
- Consultants
- Distributors
SCOPE OF THE REPORT
The scope of this report covers the market by its major segments, which include as follows:
GLOBAL BLOOD PREPARATION MARKET KEY PLAYERS
- Pfizer
- Bayer
- GlaxoSmithKline
- Boehringer Ingelheim
- Aralez Pharmaceuticals
- AstraZeneca
- Leo Pharma
- Bristol-Myers
- Ionis Pharmaceuticals
- Johnson and Johnson
GLOBAL BLOOD PREPARATION MARKET, BY PRODUCT TYPES
- Whole Blood
- Red Cells
- Granulocytes
- Plasma
- Platelets
- Blood Components
- Whole Blood Components
- Packed Red Cells
- Leukocyte Reduced Red Blood Cells
- Frozen Plasma
- Platelet Concentrate
- Cryoprecipitate
- Blood Derivatives
GLOBAL BLOOD PREPARATION MARKET, BY ANTITHROMBOTIC AND ANTICOAGULANTS TYPE
- Platelet Aggregation Inhibitors
- Glycoprotein Inhibitors
- COX Inhibitors
- ADP Antagonists
- Others
- Fibrinolytics
- Tissue Plasminogen Activator (tPA)
- Streptokinase
- Urokinase
- Anticoagulants
- Heparins
- Vitamin K Antagonists
- Direct Thrombin Inhibitors
- Direct Factor Xa Inhibitors
GLOBAL BLOOD PREPARATION MARKET, BY APPLICATION
- Thrombocytosis
- Pulmonary Embolism
- Renal Impairment
- Angina Blood Vessel Complications
- Others
GLOBAL BLOOD PREPARATION MARKET, BY REGION
- North America
- The U.S.
- Canada
- Europe
- Germany
- France
- Italy
- Spain
- United Kingdom
- Rest of Europe
- Asia Pacific
- India
- China
- South Korea
- Japan
- Singapore
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- The Middle East and Africa
- Saudi Arabia
- United Arab Emirates
- Rest of MEA
"
TABLE OF CONTENT
1. BLOOD PREPARATION MARKET OVERVIEW
1.1. Study Scope
2. EXECUTIVE SUMMARY
2.1. Market Snippet
2.1.1. Market Snippet by Product
2.1.2. Market Snippet by Antithrombotic and Anticoagulants Type
2.1.3. Market Snippet by Application
2.1.4. Market Snippet by Region
2.2. Competitive Insights
3. BLOOD PREPARATION KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. BLOOD PREPARATION INDUSTRY STUDY
4.1. Porter’s Five Forces Analysis
4.2. Marketing Strategy Analysis
4.3. Growth Prospect Mapping
4.4. Regulatory Framework Analysis
5. BLOOD PREPARATION MARKET: COVID-19 IMPACT ANALYSIS
5.1. Pre-COVID-19 Impact Analysis
5.2. Post-COVID-19 Impact Analysis
5.2.1. Top Performing Segments
5.2.2. Marginal Growth Segments
5.2.3. Top Looser Segments
5.2.4. Marginal Loss Segments
6. BLOOD PREPARATION MARKET LANDSCAPE
6.1. Market Share Analysis, 2019
6.2. Key Innovators Analysis
6.3. Breakdown Data, by Key Manufacturer
6.3.1. Established Players’ Analysis
6.3.2. Emerging Players’ Analysis
7. BLOOD PREPARATION MARKET – BY PRODUCT
7.1. Overview
7.1.1. Segment Share Analysis, By Product, 2020 & 2027 (%)
7.2. Whole Blood
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.2.3. Red Cells
7.2.3.1. Overview
7.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.2.4. Granulocytes
7.2.4.1. Overview
7.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.2.5. Plasma
7.2.5.1. Overview
7.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.2.6. Platelets
7.2.6.1. Overview
7.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.3. Blood Components
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.3.3. Whole Blood Components
7.3.3.1. Overview
7.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.3.4. Packed Red Cells
7.3.4.1. Overview
7.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.3.5. Leukocyte Reduced Red Blood Cells
7.3.5.1. Overview
7.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.3.6. Frozen Plasma
7.3.6.1. Overview
7.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.3.7. Platelet Concentrate
7.3.7.1. Overview
7.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.3.8. Cryoprecipitate
7.3.8.1. Overview
7.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
7.4. Blood Derivatives
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
8. BLOOD PREPARATION MARKET – BY ANTITHROMBOTIC AND ANTICOAGULANTS TYPE
8.1. Overview
8.1.1. Segment Share Analysis, By Product, 2020 & 2027 (%)
8.2. Platelet Aggregation Inhibitors
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
8.2.3. Glycoprotein Inhibitors
8.2.3.1. Overview
8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
8.2.4. COX Inhibitors
8.2.4.1. Overview
8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
8.2.5. ADP Antagonists
8.2.5.1. Overview
8.2.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
8.2.6. Others
8.2.6.1. Overview
8.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
8.3. Fibrinolytics
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
8.3.3. Tissue Plasminogen Activator (tPA)
8.3.3.1. Overview
8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
8.3.4. Streptokinase
8.3.4.1. Overview
8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
8.3.5. Urokinase
8.3.5.1. Overview
8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
8.4. Anticoagulants
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
8.4.3. Heparins
8.4.3.1. Overview
8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
8.4.4. Vitamin K Antagonists
8.4.4.1. Overview
8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
8.4.5. Direct Thrombin Inhibitors
8.4.5.1. Overview
8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
8.4.6. Direct Factor Xa Inhibitors
8.4.6.1. Overview
8.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9. BLOOD PREPARATION MARKET – BY APPLICATION
9.1. Overview
9.1.1. Segment Share Analysis, By Application, 2020 & 2027 (%)
9.2. Thrombocytosis
9.2.1. Overview
9.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.3. Pulmonary Embolism
9.3.1. Overview
9.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.4. Angina Blood Vessel Complications
9.4.1. Overview
9.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.5. Renal Impairment
9.5.1. Overview
9.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
9.6. Others
9.6.1. Overview
9.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10. BLOOD PREPARATION MARKET– BY GEOGRAPHY
10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2020 & 2027 (%)
10.2. North America
10.2.1. Overview
10.2.2. Key Manufacturers in North America
10.2.3. North America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
10.2.4. North America Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.2.5. North America Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.2.6. North America Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.2.7. U.S.
10.2.7.1. Overview
10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.2.7.3. U.S. Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.2.7.4. U.S. Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.2.7.5. U.S. Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.2.8. Canada
10.2.8.1. Overview
10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.2.8.3. Canada Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.2.8.4. Canada Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.2.8.5. Canada Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.3. Europe
10.3.1. Overview
10.3.2. Key Manufacturers in North America
10.3.3. Europe Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
10.3.4. Europe Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.3.5. Europe Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.3.6. Europe Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.3.7. Germany
10.3.7.1. Overview
10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.3.7.3. Germany Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.3.7.4. Germany Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.3.7.5. Germany Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.3.8. Italy
10.3.8.1. Overview
10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.3.8.3. Italy Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.3.8.4. Italy Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.3.8.5. Italy Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.3.9. United Kingdom
10.3.9.1. Overview
10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.3.9.3. United Kingdom Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.3.9.4. United Kingdom Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.3.10. France
10.3.10.1. Overview
10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.3.10.3. France Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.3.10.4. France Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.3.10.5. France Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.3.11. Rest of Europe
10.3.11.1. Overview
10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.3.11.3. Rest of the Europe Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.3.11.4. Rest of the Europe Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.3.11.5. Rest of the Europe Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.4. Asia Pacific (APAC)
10.4.1. Overview
10.4.2. Key Manufacturers in Asia Pacific
10.4.3. Asia Pacific Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
10.4.4. Asia Pacific Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.4.5. Asia Pacific Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.4.6. Asia Pacific Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.4.7. India
10.4.7.1. Overview
10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.4.7.3. India Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.4.7.4. India Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.4.7.5. India Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.4.8. China
10.4.8.1. Overview
10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.4.8.3. China Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.4.8.4. China Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.4.8.5. China Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.4.9. Japan
10.4.9.1. Overview
10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.4.9.3. Japan Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.4.9.4. Japan Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.4.9.5. Japan Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.4.10. South Korea
10.4.10.1. Overview
10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.4.10.3. South Korea Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.4.10.4. South Korea Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.4.10.5. South Korea Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.4.11. Rest of APAC
10.4.11.1. Overview
10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.4.11.3. Rest of APAC Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.4.11.4. Rest of APAC Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.4.11.5. Rest of APAC Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.5. Latin America
10.5.1. Overview
10.5.2. Key Manufacturers in Latin America
10.5.3. Latin America Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
10.5.4. Latin America Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.5.5. Latin America Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.5.6. Latin America Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.5.7. Brazil
10.5.7.1. Overview
10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.5.7.3. Brazil Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.5.7.4. Brazil Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.5.7.5. Brazil Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.5.8. Mexico
10.5.8.1. Overview
10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.5.8.3. Mexico Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.5.8.4. Mexico Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.5.8.5. Mexico Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.5.9. Argentina
10.5.9.1. Overview
10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.5.9.3. Argentina Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.5.9.4. Argentina Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.5.9.5. Argentina Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
1.1.1. Rest of LATAM
10.5.9.6. Overview
10.5.9.7. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.5.9.8. Rest of LATAM Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.5.9.9. Rest of LATAM Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.5.9.10. Rest of LATAM Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.6. Middle East and Africa
10.6.1. Overview
10.6.2. Key Manufacturers in Middle East and Africa
10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2016 - 2027 (US$ Million)
10.6.4. Middle East and Africa Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.6.5. Middle East and Africa Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.6.7. Saudi Arabia
10.6.7.1. Overview
10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.6.7.3. Saudi Arabia Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.6.7.4. Saudi Arabia Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
10.6.8. United Arab Emirates
10.6.8.1. Overview
10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2016 - 2027, (US$ Million)
10.6.8.3. United Arab Emirates Market Size and Forecast, By Product, 2016 - 2027 (US$ Million)
10.6.8.4. United Arab Emirates Market Size and Forecast, By Antithrombotic and Anticoagulants Type, 2016 - 2027 (US$ Million)
10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2016 - 2027 (US$ Million)
11. KEY VENDOR ANALYSIS
11.1. Competitive Dashboard
11.2. Company Profiles
11.2.1. Pfizer
11.2.1.1. Company Snapshot
11.2.1.2. Financial Performance
11.2.1.3. Product Benchmarking
11.2.1.4. Strategic Initiatives
11.2.2. Bayer
11.2.3. GlaxoSmithKline
11.2.4. Boehringer Ingelheim
11.2.5. Aralez Pharmaceuticals
11.2.6. AstraZeneca
11.2.7. Leo Pharma
11.2.8. Bristol-Myers
11.2.9. Ionis Pharmaceuticals
11.2.10. Johnson and Johnson
12. 360 DEGREE ANALYSTVIEW
13. APPENDIX
13.1. Research Methodology
13.2. References
13.3. Abbreviations
13.4. Disclaimer
13.5. Contact Us
